Form 4: Guardant Health CIO Kalia's RSU Vesting & Tax Withholding

Guardant Health's Chief Information Officer, Kumud Kalia, reported the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations.

Summary

• Kumud Kalia, Chief Information Officer of Guardant Health, Inc., reported multiple transactions on January 1, 2026.
• These transactions primarily involved the vesting of various Restricted Stock Unit (RSU) and Performance-Based Restricted Stock Unit (PBRSU) awards.
• A total of 1,607, 12,856, 1,083, 3,696, and 1,995 shares of Common Stock were acquired through the vesting of these awards.
• Concurrently, 9,392 shares of Common Stock were disposed of at a price of $102.14 per share to satisfy tax withholding obligations related to the vesting of an RSU installment.
• Following these reported transactions, Kumud Kalia beneficially owns 34,524 shares of Guardant Health, Inc. Common Stock directly.

Sentiment

Score: 6

Explanation: The filing reflects routine executive compensation events, specifically the vesting of equity awards and associated tax withholding. While the vesting is positive for the individual, the tax-related sale is a neutral, expected event for the company. It doesn't indicate any significant positive or negative operational news for Guardant Health.

Positives

• Vesting of 1,607 Restricted Stock Units (RSUs) from a November 7, 2022 grant.
• Vesting of 12,856 Performance-Based Restricted Stock Units (PBRSUs) from a June 7, 2023 grant, indicating achievement of performance metrics.
• Vesting of 1,083 Restricted Stock Units (RSUs) from a December 13, 2023 grant.
• Vesting of 3,696 Performance-Based Restricted Stock Units (PBRSUs) from a February 26, 2024 grant, indicating achievement of performance metrics.
• Vesting of 1,995 Restricted Stock Units (RSUs) from a November 8, 2024 grant.

Negatives

• 9,392 shares of Common Stock were disposed of at $102.14 per share to cover tax withholding obligations, reducing the number of shares beneficially owned.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details routine insider transactions related to executive compensation and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The disposition of shares for tax purposes slightly increases the public float but is a routine event and unlikely to have a material impact on share price. The vesting of RSUs represents a planned dilution as part of executive compensation.
• Employees: The vesting of equity awards for a key executive reinforces the company's compensation structure and may serve as an incentive for other employees.

Next Steps

• The remaining 75% of the RSU award granted on November 7, 2022, will vest in equal quarterly installments over the remaining three-year period after October 1, 2023.
• The remaining 67% of the RSU award granted on December 13, 2023, will vest in equal quarterly installments over the remaining two-year period after October 1, 2024.
• The remaining 34% of the Performance-Based RSU award granted on February 26, 2024, will vest on January 1, 2027.
• The remaining 67% of the RSU award granted on November 8, 2024, will vest in equal quarterly installments over the remaining two-year period after October 1, 2025.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (vesting of restricted stock units and subsequent tax withholding). It does not provide any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, assuming an investor's existing thesis on Guardant Health remains unchanged by this administrative filing.

Keywords

Guardant Health, GH, Kumud Kalia, Form 4, Insider Trading, Restricted Stock Units, Performance-Based Restricted Stock Units, Stock Vesting, Tax Withholding, Officer Transactions